Outset Medical Inc. (OM) Tops Q4 EPS by 5c, provides guidance

Outset Medical Inc. (NASDAQ: OM) reported Q4 EPS of ($0.59), $0.05 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $30.5 million versus the consensus estimate of $30.13 million.

GUIDANCE:

Outset Medical Inc. sees Q1 2024 revenue of $145-153 million, versus the consensus of $148.9 million.

For earnings history and earnings-related data on Outset Medical Inc. (OM) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits